(NASDAQ: CVRX) Cvrx's forecast annual revenue growth rate of 12.56% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.64%.
Cvrx's revenue in 2025 is $55,969,000.On average, 9 Wall Street analysts forecast CVRX's revenue for 2025 to be $1,498,772,663, with the lowest CVRX revenue forecast at $1,428,136,419, and the highest CVRX revenue forecast at $1,554,914,716. On average, 9 Wall Street analysts forecast CVRX's revenue for 2026 to be $1,742,421,836, with the lowest CVRX revenue forecast at $1,643,898,036, and the highest CVRX revenue forecast at $1,860,393,537.
In 2027, CVRX is forecast to generate $2,115,889,679 in revenue, with the lowest revenue forecast at $1,926,443,012 and the highest revenue forecast at $2,380,533,150.